Treatment target pinpointed for liver cancer in teens and young adults

(University of Washington Health Sciences/UW Medicine) New findings show how a genetically aberrant, fused protein molecule, created by a liver cell mutation, promotes a rare, difficult to treat, cancer in young people. By screening several drug combinations, researchers found a set that targeted both the fused protein and the enzymes that it recruits. In the lab, this mix of drugs slowed down uncontrolled growth of mouse cells engineered to carry the cancer-causing mutation.
Source: EurekAlert! - Biology - Category: Biology Source Type: news